The rising cost of health insurance in the United States is a pressing concern, with premiums for employer-sponsored insurance expected to increase by 9% in 2026. Public spending on Medicare, Medicaid, and Obamacare is also surging. However, this increase is not due to excessive profits among insurers or hospitals, but rather the rising cost of care, driven by higher utilization of medical services, particularly newly developed drugs and outpatient procedures.

The hospital industry is often blamed for driving up healthcare costs, but the reality is more complex. While hospital procedures account for a significant portion of healthcare spending, 80% of US hospitals are publicly owned or non-profits, and the most expensive facilities are often small, rural hospitals facing declining revenues. Additionally, average prices for hospital care have actually fallen 2% in real terms since 2010.

Similarly, physician fees are not the primary driver of rising healthcare costs. Payments for treating Medicare patients are often fixed by law, and physician fees have fallen 18% in real terms since 2010. Prescription drug prices have also declined, with the average real price of prescriptions for Medicare enrollees decreasing by 13% between 2009 and 2018.

The true driver of rising healthcare costs is the expansion of medical capabilities, leading to increased demand for medical services. Americans are consuming more healthcare, and the willingness to spend more to alleviate illness and infirmity has no real limit. The introduction of new technologies and treatments has transformed the healthcare landscape, with significant advancements in areas such as cardiovascular disease, cancer, and HIV-AIDS.

However, this increased utilization of medical services has led to higher healthcare costs. From 2014 to 2023, the number of medical practitioners increased from 6.5 million to 9.6 million, and the volume of physician services delivered per Medicare beneficiary grew by 45% in orthopedics, 50% in neurosurgery, and 130% in surgical oncology.

To control healthcare costs, policymakers must reform payment systems to reward cost-saving innovations. This could involve indirect payments for newly developed medical technologies, rather than establishing supplemental funding streams. Additionally, switching control over the purchase of insurance from employers to individual workers could improve incentives for private insurance to control healthcare costs.

Ultimately, the rising cost of health insurance is a complex issue, driven by a range of factors, including increased utilization of medical services, technological advancements, and payment system incentives. Addressing these challenges will require a nuanced and multifaceted approach, one that balances the need for innovation and access to quality care with the need to control costs and ensure affordability.